P
Pierre Whitlock
Publications - 1
Citations - 201
Pierre Whitlock is an academic researcher. The author has contributed to research in topics: Docetaxel & Combination chemotherapy. The author has an hindex of 1, co-authored 1 publications receiving 180 citations.
Papers
More filters
Journal ArticleDOI
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial
John R. Mackey,Miguel Martin,Tadeusz Pienkowski,Janusz Rolski,Jean-Paul Guastalla,Amer Sami,John A. Glaspy,Eva Juhos,Andrew M Wardley,Tommy Fornander,John D. Hainsworth,Robert E. Coleman,Manuel Modiano,J. Vinholes,Tamás Pintér,Álvaro Rodríguez-Lescure,Bruce Colwell,Pierre Whitlock,Louise Provencher,Kara Laing,David Walde,Chris Price,Judith Hugh,Barrett H. Childs,Kimberly Bassi,Mary Ann Lindsay,Véronique Wilson,Matthieu Rupin,Vincent Houe,C Vogel +29 more
TL;DR: The results provide evidence that the initial therapeutic outcomes seen at the 5-year follow-up with a docetaxel-containing adjuvant regimen are maintained at 10 years, however, a substantial percentage of patients had a decrease in left ventricular ejection fraction, probably caused by anthracycline therapy, which warrants further investigation.